NGM Biopharmaceuticals Inc buy melinda
Start price
08.03.20
/
50%
€15.90
Target price
04.11.21
€18.00
Performance (%)
-16.98%
End price
07.06.21
€13.20
Summary
This prediction ended on 07.06.21 with a price of €13.20. The prediction for NGM Biopharmaceuticals Inc disappointed with a performance of -16.98%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
NGM Biopharmaceuticals Inc | - | - | - | - |
iShares Core DAX® | -1.414% | 7.218% | 17.151% | 15.732% |
iShares Nasdaq 100 | -2.316% | 4.450% | 18.360% | 30.945% |
iShares Nikkei 225® | -2.756% | 10.071% | 10.704% | 2.733% |
iShares S&P 500 | -1.849% | 4.760% | 19.639% | 34.852% |
According to melinda what are the pros and cons of NGM Biopharmaceuticals Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread NGM Biopharmaceuticals Inc diskutieren
Buy mit Kursziel 18,0
In the thread Trading NGM Biopharmaceuticals Inc
Buy beendet
Stopped prediction by melinda for NGM Biopharmaceuticals Inc
NGM Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€13.20
07.06.21
07.06.21
€15.00
07.06.22
07.06.22
-3.03%
08.06.22
08.06.22
Could be worthwhile Investment >10% per year